Keywords: L-dopa، levodopa; PD, Parkinson’s disease; DAergic, dopaminergic; SNpc, substantia nigra pars compacta; DA, dopamine; LB, lewy body; α-syn, alpha synuclein; L-DOPA, levodopa; MAO, monoamine oxidase; CNS, central nervous system; DDS, drug delivery systems; MPs, microparticl
مقالات ISI L-dopa، levodopa (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Alterations of miRNAs reveal a dysregulated molecular regulatory network in Parkinson’s disease striatum
Keywords: L-dopa، levodopa; PD, Parkinson’s disease; CNS, central nervous system; DA, dopamine; miRNA, microRNA; mRNA, messenger RNA; RIN, RNA integrity number; L-dopa, levodopa; LID, L-dopa induced dyskinesia; DE, differentially expressed; LTP, long term potentiation; TNFSF13B, TNF
Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson’s disease
Keywords: L-dopa، levodopa; A, adenosine; DA, dopamine; CNS, central nervous system; CREB, cAMP response element-binding protein; DAT, dopamine transporter; ERK, extracellular signal-regulated kinase; ER, estrogen receptor; ERKO, estrogen receptor knock out; L-DOPA, levodopa; MAPK,
Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration
Keywords: L-dopa، levodopa; L-DOPA, levodopa; PD, Parkinson disease; COMT, catechol-O-methyltransferase; 3-OMD, 3-O-methyldopa; CNS, central nervous system; H2-DCF-DA, 2′,7′-dichlorofluorescein diacetate; AdoMet, S-adenosyl-L-methionine; ROS, reactive oxygen species; MTT, 3-(4,5-dim
Genetically engineered mouse models of Parkinson's disease
Keywords: L-dopa، levodopa; MPTP, 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine; MPP+, 1-methyl-4-phenylpyridinium; 6-OHDA, 6-hydroxydopamine; COMT, catechol-O-methyltransferase; DA, dopamine; DAT, dopamine transporter; L-DOPA, levodopa; LB, Lewy body; LPS, lipopolysaccharride; MAOB,
Targeting the Subthalamic Nucleus for Deep Brain Stimulation—A Comparative Study Between Magnetic Resonance Images Alone and Fusion with Computed Tomographic Images
Keywords: L-dopa، levodopa; Computed tomography; Image fusion; Magnetic resonance images; Parkinson's disease; Subthalamic nucleusAC-PC, Anterior and posterior commissures; CT, Computed tomography; DBS, Deep brain stimulation; L-dopa, Levodopa; LEDD, Levodopa equivalent daily dose;
Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys
Keywords: L-dopa، levodopa; Akt, protein kinase B; BSA, bovine serum albumin; DA, dopamine; GSK3, glycogen synthase kinase-3; 6-OHDA, 6-hydroxydopamine; L-Dopa, Levodopa; LID, L-Dopa-induced dyskinesias; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; mTORC2, mTOR complex 2; NMD
Gait Analysis in Patients With Parkinson's Disease Off Dopaminergic Therapy
Keywords: L-dopa، levodopa; Biomechanics; Levodopa; Neurologic gait disorders; Parkinson Disease; RehabilitationPD, Parkinson's disease; L-dopa, levodopa; ROM, range of motion
Subchronic administration of l-DOPA to adult rats with a unilateral 6-hydroxydopamine lesion of dopamine neurons results in a sensitization of enhanced GABA release in the substantia nigra, pars reticulata
Keywords: L-dopa، levodopa; GABA, gamma-aminobutyric acid; l-DOPA, levodopa; SNr, substantia nigra pars reticulata; EP, entopeduncular nucleus; HPLC, high-performance liquid chromatographyBasal ganglia; 6-hydroxydopamine; GABA; Levodopa; Dyskinesia; Substantia nigra reticulata
Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's β-amyloid fibrils in vitro
Keywords: L-dopa، levodopa; Aβ, amyloid β-peptide; AD, Alzheimer's disease; Bro, bromocriptine; Cat, catechin; Cur, curcumin; DMSO, dimethyl sulfoxide; EC50, effective concentrations at 50% value; epi-Cat, epicatechin; fAβ, β-amyloid fibrils; Kmp, kaempferol; l-Dopa, levodopa; MAO-B